{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:39:46Z","timestamp":1792622386153,"version":"4.5.0"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023621","name":"University of Illinois College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["5 I01 BX004697"],"award-info":[{"award-number":["5 I01 BX004697"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117417","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:58Z","timestamp":1760144998000},"page":"117417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P4","title":["Multi-oncogene targeting in cancer therapy: A miRNA-driven pharmacological approach"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0555-0743","authenticated-orcid":false,"given":"Satyajeet S.","family":"Salunkhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Ghatage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellur S.","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"issue":"6808","key":"10.1016\/j.bcp.2025.117417_b0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35040556","article-title":"Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA","volume":"408","author":"Pasquinelli","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12864-025-11254-0","article-title":"Predicting microRNA target genes using pan-cancer correlation patterns","volume":"26","author":"Lin","year":"2025","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13148-016-0200-y","article-title":"Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells","volume":"8","author":"Butkyt\u0117","year":"2016","journal-title":"Clin. Epigenetics"},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","article-title":"The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease","volume":"18","author":"Concepcion","year":"2012","journal-title":"The Cancer Journal"},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3727\/096504015X14496932933575","article-title":"Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells","volume":"23","author":"Liu","year":"2016","journal-title":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0035","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1261\/rna.7135204","article-title":"Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs","volume":"10","author":"Cai","year":"2004","journal-title":"RNA"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nsmb1167","article-title":"RNA polymerase III transcribes human microRNAs","volume":"13","author":"Borchert","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7014","key":"10.1016\/j.bcp.2025.117417_b0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","article-title":"The Microprocessor complex mediates the genesis of microRNAs","volume":"432","author":"Gregory","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1261\/rna.5167604","article-title":"Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs","volume":"10","author":"Bohnsack","year":"2004","journal-title":"RNA"},{"issue":"7951","key":"10.1016\/j.bcp.2025.117417_b0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41586-023-05723-3","article-title":"Structure of the human DICER\u2013pre-miRNA complex in a dicing state","volume":"615","author":"Lee","year":"2023","journal-title":"Nature"},{"issue":"7299","key":"10.1016\/j.bcp.2025.117417_b0060","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature09039","article-title":"Structural basis for 5\u2032-nucleotide base-specific recognition of guide RNA by human AGO2","volume":"465","author":"Frank","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0065","article-title":"Reassessment of miRNA variant (isomiRs) composition by small RNA sequencing","volume":"3","author":"G\u00f3mez-Mart\u00edn","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.bcp.2025.117417_b0070","doi-asserted-by":"crossref","unstructured":"Y. Kawahara, B. Zinshteyn, P. Sethupathy, H. Iizasa, A. G. Hatzigeorgiou, and K. Nishikura, \u2018Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs\u2019, Science (1979), vol. 315, no. 5815, pp. 1137\u20131140, Feb. 2007, doi: 10.1126\/science.1138050.","DOI":"10.1126\/science.1138050"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0075","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41598-024-52681-5","article-title":"Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers","volume":"14","author":"Sandau","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0080","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0085","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1101\/gr.278073.123","article-title":"ZSWIM8 destabilizes many murine microRNAs and is required for proper embryonic growth and development","volume":"33","author":"Shi","year":"2023","journal-title":"Genome Res."},{"key":"10.1016\/j.bcp.2025.117417_b0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2020.07.007","article-title":"CD40-miRNA axis controls prospective cell fate determinants during B cell differentiation","volume":"126","author":"Salunkhe","year":"2020","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0095","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12916-024-03789-y","article-title":"Multiomics profiling of DNA methylation, microRNA, and mRNA in skeletal muscle from monozygotic twin pairs discordant for type 2 diabetes identifies dysregulated genes controlling metabolism","volume":"22","author":"Ling","year":"2024","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0100","doi-asserted-by":"crossref","first-page":"Nov","DOI":"10.1093\/bib\/bbae616","article-title":"miCGR: interpretable deep neural network for predicting both site-level and gene-level functional targets of microRNA","volume":"26","author":"Wu","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0105","doi-asserted-by":"crossref","first-page":"17922","DOI":"10.1038\/s41598-024-68945-z","article-title":"Identification and validation of miRNA-target genes network in pediatric brain tumors","volume":"14","author":"Gruszka","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009962","article-title":"Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors","volume":"18","author":"Poorebrahim","year":"2022","journal-title":"PLoS Comput. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310315","article-title":"miR-379-5p affects breast cancer cell behavior by targeting UBE2E3 ubiquitin conjugating enzyme","volume":"19","author":"Schroder","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117417_b0120","doi-asserted-by":"crossref","unstructured":"Q. Wang et al., \u2018miR-668: A versatile microrna with disease-specific roles and therapeutic applications\u2019, LabMed Discovery, p. 100028, Dec. 2024, doi: 10.1016\/j.lmd.2024.100028.","DOI":"10.1016\/j.lmd.2024.100028"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.18632\/oncotarget.417","article-title":"Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma","volume":"3","author":"Hidaka","year":"2012","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"63","key":"10.1016\/j.bcp.2025.117417_b0135","doi-asserted-by":"crossref","first-page":"107167","DOI":"10.18632\/oncotarget.22363","article-title":"About miRNAs, miRNA seeds, target genes and target pathways","volume":"8","author":"Kehl","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.bcp.2025.117417_b0140","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1093\/nar\/gkx706","article-title":"A comprehensive, cell specific microRNA catalogue of human peripheral blood","volume":"45","author":"Juzenas","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bcp.2025.117417_b0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41594-018-0136-3","article-title":"A novel class of microRNA-recognition elements that function only within open reading frames","volume":"25","author":"Zhang","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0150","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1101\/gr.139758.112","article-title":"Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation","volume":"23","author":"Hausser","year":"2013","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0155","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1261\/rna.044792.114","article-title":"The role of RNA structure at 5\u2032 untranslated region in microRNA-mediated gene regulation","volume":"20","author":"Gu","year":"2014","journal-title":"RNA"},{"issue":"7","key":"10.1016\/j.bcp.2025.117417_b0160","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1101\/gr.089367.108","article-title":"New class of microRNA targets containing simultaneous 5\u2032-UTR and 3\u2032-UTR interaction sites","volume":"19","author":"Lee","year":"2009","journal-title":"Genome Res."},{"issue":"D1","key":"10.1016\/j.bcp.2025.117417_b0165","doi-asserted-by":"crossref","first-page":"D333","DOI":"10.1093\/nar\/gkab825","article-title":"RNALocate v2.0: an updated resource for RNA subcellular localization with increased coverage and annotation","volume":"50","author":"Cui","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0170","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/srep02535","article-title":"microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus","volume":"3","author":"Leucci","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-024-01355-3","article-title":"Astrocyte\u2013neuron crosstalk through extracellular vesicle-shuttled miRNA-382-5p promotes traumatic brain injury","author":"Hu","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12964-023-01259-1","article-title":"Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN\/MADD targeting in the NF-\u03baB signaling pathways","volume":"21","author":"Otmani","year":"2023","journal-title":"Cell Commun. Signaling"},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-18-0517","article-title":"MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer","volume":"26","author":"Saini","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"W1","key":"10.1016\/j.bcp.2025.117417_b0190","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gkab297","article-title":"miRTargetLink 2.0\u2014interactive miRNA target gene and target pathway networks","volume":"49","author":"Kern","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117417_b0195","article-title":"Single-cell genomics breaks new ground in cell cycle detection","author":"Du","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2025.117417_b0200","doi-asserted-by":"crossref","unstructured":"M. Naderi Boldaji, S. Shahbazi, S. Reiisi, K. Ahmadi, and M. Mahdevar, \u2018Construction of a cell cycle-specific lncRNA-miRNA-mRNA network reveals novel key lncRNAs in colorectal cancer\u2019, Biomarkers, vol. 29, no. 8, pp. 565\u2013576, Nov. 2024, doi: 10.1080\/1354750X.2024.2431015.","DOI":"10.1080\/1354750X.2024.2431015"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13059-024-03438-w","article-title":"Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors","volume":"25","author":"Merk","year":"2024","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41419-017-0243-9","article-title":"KRAS induces lung tumorigenesis through microRNAs modulation","volume":"9","author":"Shi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41419-024-06744-0","article-title":"A novel TGFbeta\/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression","volume":"15","author":"Qin","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-022-00840-4","article-title":"MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells","volume":"20","author":"Maharati","year":"2022","journal-title":"Cell Commun. Signaling"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0225","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1038\/s41598-024-52940-5","article-title":"MicroRNA-203a inhibits breast cancer progression through the PI3K\/Akt and Wnt pathways","volume":"14","author":"Entezari","year":"2024","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2025.117417_b0230","doi-asserted-by":"crossref","first-page":"18382","DOI":"10.1002\/jcp.28472","article-title":"MicroRNA\u2010524\u20105p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"67","key":"10.1016\/j.bcp.2025.117417_b0235","doi-asserted-by":"crossref","first-page":"111405","DOI":"10.18632\/oncotarget.22808","article-title":"A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells","volume":"8","author":"Al-Asadi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117417_b0240","first-page":"1","article-title":"High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma","volume":"2018","author":"Huang","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0245","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13148-023-01448-2","article-title":"Phospholipase C delta 1 inhibits WNT\/\u03b2\u2010catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma","volume":"15","author":"Xie","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0250","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s12885-023-11113-9","article-title":"MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt\/\u03b2-catenin signaling pathway","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2025.117417_b0255","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41419-023-06021-6","article-title":"Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma","volume":"14","author":"Xiang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0260","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-23-0954","article-title":"INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle arrest and Senescence in Solid Tumors","volume":"14","author":"Dietrich","year":"2024","journal-title":"Cancer Discov."},{"issue":"23","key":"10.1016\/j.bcp.2025.117417_b0265","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.3390\/ijms252312974","article-title":"Exploring Bioinformatics Tools to Analyze the Role of CDC6 in the Progression of Polycystic Ovary Syndrome to Endometrial Cancer by Promoting Immune Infiltration","volume":"25","author":"Song","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12885-023-11766-6","article-title":"microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0275","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1038\/s41598-023-35059-x","article-title":"Mir-183 functions as an oncogene via decreasing PTEN in breast cancer cells","volume":"13","author":"Mohammaddoust","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b0280","article-title":"Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0285","doi-asserted-by":"crossref","first-page":"29950","DOI":"10.1038\/s41598-024-81541-5","article-title":"WWP1 targeting PTEN for polyubiquitination to promote bone metastasis of luminal breast cancer","volume":"14","author":"Jiang","year":"2024","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bcp.2025.117417_b0290","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.devcel.2024.08.003","article-title":"Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression","volume":"59","author":"Zhang","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2025.117417_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00107","article-title":"In vitro Cell Migration, Invasion, and Adhesion Assays: from Cell Imaging to Data Analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"23","key":"10.1016\/j.bcp.2025.117417_b0300","doi-asserted-by":"crossref","first-page":"9570","DOI":"10.1158\/0008-5472.CAN-10-2074","article-title":"MicroRNA miR-183 Functions as an Oncogene by Targeting the Transcription factor EGR1 and Promoting Tumor Cell Migration","volume":"70","author":"Sarver","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2016.02.006","article-title":"MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer","volume":"141","author":"Fan","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0310","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3892\/ijmm.2015.2123","article-title":"microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53","volume":"35","author":"Wang","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0315","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1073\/pnas.96.5.2147","article-title":"p53 regulates a G 2 checkpoint through cyclin B1","volume":"96","author":"Innocente","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b0320","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/MCB.22.6.1819-1833.2002","article-title":"Overexpression of c-Myc Alters G1\/S arrest following Ionizing Radiation","volume":"22","author":"Sheen","year":"2002","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10571-024-01510-4","article-title":"Identification of miRNA-TF Regulatory Pathways Related to Diseases from a Neuroendocrine-Immune Perspective","volume":"45","author":"Wang","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117417_b0330","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41388-021-02084-x","article-title":"MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers","volume":"41","author":"Desi","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117417_b0335","doi-asserted-by":"crossref","unstructured":"R. Shah Hosseini et al., \u2018The p53\/miRNA Axis in Breast Cancer\u2019, DNA Cell Biol, vol. 43, no. 11, pp. 549\u2013558, Nov. 2024, doi: 10.1089\/dna.2024.0181.","DOI":"10.1089\/dna.2024.0181"},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0345","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0350","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b0355","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/nu16060873","article-title":"Ferroptosis Altered microRNAs Expression in HT-1080 Fibrosarcoma Cells based on Small RNA Sequencing and Bioinformatics Analysis","volume":"16","author":"Zhang","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2025.117417_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102891","article-title":"Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis","volume":"88","author":"Davies","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0365","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1038\/s41598-024-61849-y","article-title":"Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer","volume":"14","author":"Qin","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.113948","article-title":"Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma","volume":"436","author":"Zhang","year":"2024","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.bcp.2025.117417_b0375","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/1878-0261.13036","article-title":"Cotargeting of miR\u2010126\u20103p and miR\u2010221\u20103p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling","volume":"15","author":"Di Paolo","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2025.117417_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles","volume":"18","author":"Sanaei","year":"2022","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0385","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects","volume":"19","author":"Lee","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0390","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.3390\/ijms15058458","article-title":"MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN","volume":"15","author":"Geng","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0395","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1038\/srep13445","article-title":"Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression","volume":"5","author":"Xia","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0400","first-page":"3827","article-title":"\u2018miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.\u2019, Int","volume":"8","author":"Xie","year":"2015","journal-title":"J Clin Exp Pathol"},{"issue":"29","key":"10.1016\/j.bcp.2025.117417_b0405","doi-asserted-by":"crossref","first-page":"27214","DOI":"10.18632\/oncotarget.4877","article-title":"Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer","volume":"6","author":"Dhar","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/nan.12169","article-title":"miR106b is overexpressed in medulloblastomas and interacts directly with PTEN","volume":"41","author":"Li","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0415","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12967-015-0592-z","article-title":"MiR-106b induces cell radioresistance via the PTEN\/PI3K\/AKT pathways and p21 in colorectal cancer","volume":"13","author":"Zheng","year":"2015","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117417_b0420","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/abbs\/gmt106","article-title":"miR-106a confers cisplatin resistance by regulating PTEN\/Akt pathway in gastric cancer cells","volume":"45","author":"Fang","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.bcp.2025.117417_b0425","doi-asserted-by":"crossref","unstructured":"P. D. King, B. A. Lubeck, and P. E. Lapinski, \u2018Nonredundant Functions for Ras GTPase-Activating Proteins in Tissue Homeostasis\u2019, Sci Signal, vol. 6, no. 264, Feb. 2013, doi: 10.1126\/scisignal.2003669.","DOI":"10.1126\/scisignal.2003669"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13045-021-01184-1","article-title":"The roles of GTPase-activating proteins in regulated cell death and tumor immunity","volume":"14","author":"He","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117417_b0435","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2024.2368242","article-title":"Targeting guanine nucleotide exchange factors for novel cancer drug discovery","volume":"19","author":"Bannoura","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284744","article-title":"MicroRNA-708 emerges as a potential candidate to target undruggable NRAS","volume":"18","author":"Pang","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0445","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/s41467-024-47771-x","article-title":"Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma","volume":"15","author":"Pucci","year":"2024","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.bcp.2025.117417_b0450","doi-asserted-by":"crossref","first-page":"Dec","DOI":"10.1126\/sciadv.adq4274","article-title":"SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition","volume":"10","author":"Song","year":"2024","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0455","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1158\/0008-5472.CAN-20-3991","article-title":"Association between smoking history and Tumor Mutation Burden in Advanced Non\u2013Small Cell Lung Cancer","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117417_b0460","unstructured":"\u2018FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer\u2019, Jun. 2024, Accessed: Dec. 15, 2024. [Online]. Available: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-adagrasib-cetuximab-kras-g12c-mutated-colorectal-cancer#:\u223c:text=mutated%20colorectal%20cancer-,FDA%20grants%20accelerated%20approval%20to%20adagrasib%20with,KRAS%20G12C%2Dmutated%20colorectal%20cancer&text=On%20June%2021%2C%202024%2C%20the,;%20Mirati%20Therapeutics%2C%20Inc.)."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0465","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is Regulated by the let-7 MicroRNA Family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0470","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117417_b0475","article-title":"YAP1 induces bladder cancer progression and promotes immune evasion through IL-6\/ STAT3 pathway and CXCL deregulation","author":"Sadhukhan","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0480","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1158\/2159-8290.CD-23-1529","article-title":"MARK2\/MARK3 Kinases are Catalytic Codependencies of YAP\/TAZ in Human Cancer","volume":"14","author":"Klingbeil","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2025.117417_b0485","doi-asserted-by":"crossref","unstructured":"M. K. Gelbard, M. Grace, A. von Schoeler-Ames, I. Gnanou, and K. Munger, \u2018The HPV101 E7 protein shares host cellular targets and biological activities with high-risk HPV16 E7\u2019, Tumour Virus Res, p. 200300, Dec. 2024, doi: 10.1016\/j.tvr.2024.200300.","DOI":"10.1016\/j.tvr.2024.200300"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0490","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1038\/s41598-024-58704-5","article-title":"The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases","volume":"14","author":"Hussein","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b0495","doi-asserted-by":"crossref","unstructured":"Y. Xu et al., \u2018Unveiling the oncogenic role of LZTS1 in colorectal cancer\u2019, J Cell Mol Med, vol. 28, no. 14, Jul. 2024, doi: 10.1111\/jcmm.18441.","DOI":"10.1111\/jcmm.18441"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0500","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2015.02.004","article-title":"The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT\u2013mTOR signaling pathway","volume":"360","author":"Zhou","year":"2015","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0505","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41419-021-03773-x","article-title":"STAT3\/miR-135b\/NF-\u03baB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0510","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ncomms2876","article-title":"MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1","volume":"4","author":"Lin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117417_b0515","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2020.05.038","article-title":"Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-\u03baB signaling pathway","volume":"489","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2025.117417_b0520","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1298571","article-title":"The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy","volume":"14","author":"Mej\u00eda-Guarnizo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117417_b0525","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1173035","article-title":"CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients","volume":"14","author":"Vaddi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117417_b0530","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","article-title":"A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity","volume":"95","author":"Kumar","year":"2018","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0535","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.4049\/jimmunol.181.3.1806","article-title":"CTLA4 Expression is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis","volume":"181","author":"Tang","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0540","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/neuonc\/nov292","article-title":"MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints","volume":"18","author":"Wei","year":"2016","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0545","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117417_b0550","doi-asserted-by":"crossref","unstructured":"E. Ben Saad, A. Oroya, N. P. Anto, M. Bachais, and C. E. Rudd, \u2018PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity\u2019, Cell Rep, vol. 43, no. 11, p. 114907, Nov. 2024, doi: 10.1016\/j.celrep.2024.114907.","DOI":"10.1016\/j.celrep.2024.114907"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0555","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies","volume":"6","author":"Shi","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117417_b0560","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-024-06124-w","article-title":"Survival impact of hypoxia-inducible factor-1 alpha (HIF-1\u03b1) in Nucleophosmin1 mutated acute myeloid leukemia","author":"Chanswangphuwana","year":"2024","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0565","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12964-024-01957-4","article-title":"The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors","volume":"22","author":"Liaghat","year":"2024","journal-title":"Cell Commun. Signaling"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0570","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1038\/s41598-024-56511-6","article-title":"MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer","volume":"14","author":"Yousefi","year":"2024","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.bcp.2025.117417_b0575","doi-asserted-by":"crossref","first-page":"26866","DOI":"10.18632\/oncotarget.8567","article-title":"Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma","volume":"7","author":"Jasinski-Bergner","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0580","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12079-020-00546-7","article-title":"Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma","volume":"14","author":"Zheng","year":"2020","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0585","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13058-023-01716-2","article-title":"MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib","volume":"25","author":"Jonas","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0590","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10577-013-9340-5","article-title":"EdU induces DNA damage response and cell death in mESC in culture","volume":"21","author":"Kohlmeier","year":"2013","journal-title":"Chromosome Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0595","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00441-011-1213-7","article-title":"The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival","volume":"345","author":"Lehner","year":"2011","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0600","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11060-011-0621-6","article-title":"Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells","volume":"105","author":"Ross","year":"2011","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0605","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1038\/s41598-018-34696-x","article-title":"Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis","volume":"8","author":"Kumar","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0610","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12974-020-01902-5","article-title":"Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis","volume":"17","author":"McKenzie","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117417_b0615","doi-asserted-by":"crossref","unstructured":"J.-M. Peng, S.-H. Lin, M.-C. Yu, and S.-Y. Hsieh, \u2018CLIC1 recruits PIP5K1A\/C to induce cell-matrix adhesions for tumor metastasis\u2019, Journal of Clinical Investigation, vol. 131, no. 1, Jan. 2021, doi: 10.1172\/JCI133525.","DOI":"10.1172\/JCI133525"},{"key":"10.1016\/j.bcp.2025.117417_b0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00186","article-title":"Phosphatidylinositol 4-Phosphate 5-Kinases in the Regulation of T Cell Activation","volume":"7","author":"Porciello","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0625","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41598-018-20053-5","article-title":"Modulation of oncogenic miRNA biogenesis using functionalized polyamines","volume":"8","author":"Staedel","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2025.117417_b0630","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1021\/acsomega.9b01142","article-title":"Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method","volume":"4","author":"Cai","year":"2019","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.bcp.2025.117417_b0635","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/1055-9965.EPI-19-0066","article-title":"MCF-7 as a Model for Functional Analysis of Breast Cancer Risk Variants","volume":"28","author":"Booms","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bcp.2025.117417_b0640","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.2147\/OTT.S249756","article-title":"Characterization of Triple-negative Breast Cancer MDA-MB-231 Cell Spheroid Model","volume":"13","author":"Huang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bcp.2025.117417_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100302","article-title":"MicroRNA-218-5p accelerates malignant behaviors of breast cancer through LRIG1","volume":"78","author":"Chu","year":"2023","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0650","doi-asserted-by":"crossref","first-page":"470","DOI":"10.18632\/oncotarget.28608","article-title":"INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death","volume":"15","author":"Duurland","year":"2024","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117417_b0655","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01195","article-title":"Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model","volume":"10","author":"Schr\u00f6rs","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2025.117417_b0660","article-title":"CD45RO-positive memory T-Cell Density in the Tumoral Core and Invasive Margin Predict Long-Term Survival in Esophageal Squamous Cell Carcinoma","author":"Noma","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bcp.2025.117417_b0665","article-title":"Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0670","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/ph17121606","article-title":"Modulation of FOXP3 Gene Expression in OVCAR3 Cells following Rosmarinic Acid and Doxorubicin Exposure","volume":"17","author":"Toprak","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2025.117417_b0675","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.24.01118","article-title":"Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 phase III Trial","author":"Palmer","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0680","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41576-024-00749-3","article-title":"Decoding protein\u2013RNA interactions using CLIP-based methodologies","volume":"25","author":"Xiang","year":"2024","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0685","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12885-018-5246-0","article-title":"Ago HITS-CLIP expands microRNA-mRNA interactions in nucleus and cytoplasm of gastric cancer cells","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0690","article-title":"Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma","volume":"32","author":"Yuen","year":"2024","journal-title":"Molecular Therapy: Oncology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0695","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0700","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-022-03442-3","article-title":"Exhaustion of CAR T cells: potential causes and solutions","volume":"20","author":"Kouro","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117417_b0705","doi-asserted-by":"crossref","unstructured":"A. H. Rad S. M., J. C. Halpin, M. Mollaei, S. W. J. Smith Bell, N. Hirankarn, and A. D. McLellan, \u2018Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)\u2014T Cells\u2019, Cancers (Basel), vol. 13, no. 6, p. 1229, Mar. 2021, doi: 10.3390\/cancers13061229.","DOI":"10.3390\/cancers13061229"},{"key":"10.1016\/j.bcp.2025.117417_b0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T Cells hit the Tumor Microenvironment: strategies to Overcome Tumor Escape","volume":"11","author":"Rodriguez-Garcia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117417_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102038","article-title":"Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform","volume":"34","author":"Rossi","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bcp.2025.117417_b0720","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1647433","article-title":"Multiplex engineering using microRNA-mediated gene silencing in CAR T cells","volume":"16","author":"Golinelli","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b0725","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/acsabm.9b00186","article-title":"Efficient Self-Assembled MicroRNA delivery System consisting of Cholesterol-Conjugated MicroRNA and PEGylated Polycationic Polymer for Tumor Treatment","volume":"2","author":"Mun","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"84","key":"10.1016\/j.bcp.2025.117417_b0730","doi-asserted-by":"crossref","first-page":"12517","DOI":"10.1039\/C6CC07386G","article-title":"A dual-functional supramolecular hydrogel based on a spiropyran\u2013galactose conjugate for target-mediated and light-controlled delivery of microRNA into cells","volume":"52","author":"Xiao","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bcp.2025.117417_b0735","doi-asserted-by":"crossref","DOI":"10.1177\/20417314241265897","article-title":"Mechanisms of hydrogel-based microRNA delivery systems and its application strategies in targeting inflammatory diseases","volume":"15","author":"Hu","year":"2024","journal-title":"J Tissue Eng"},{"issue":"11","key":"10.1016\/j.bcp.2025.117417_b0740","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0745","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest. New Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0750","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1186\/1471-2407-14-889","article-title":"Cholesterol-conjugated let-7amimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0755","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1261\/rna.054072.115","article-title":"Double-stranded microRNA mimics can induce length- and passenger strand\u2013dependent effects in a cell type\u2013specific manner","volume":"22","author":"Goldgraben","year":"2016","journal-title":"RNA"},{"issue":"7187","key":"10.1016\/j.bcp.2025.117417_b0760","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06765","article-title":"Sequence- and target-independent angiogenesis suppression by siRNA via TLR3","volume":"452","author":"Kleinman","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0765","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/intimm\/dxt040","article-title":"Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro","volume":"26","author":"Broering","year":"2014","journal-title":"Int. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117417_b0770","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0775","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/cancers13040632","article-title":"MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117417_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104137","article-title":"Clinical decision support analysis of a microRNA-based thyroid molecular classifier: a real-world, prospective and multicentre validation study","volume":"82","author":"Santos","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0785","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/diagnostics13122078","article-title":"Advantages and Limitations of Ultrasound as a Screening Test for Ovarian Cancer","volume":"13","author":"Koutras","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.bcp.2025.117417_b0790","article-title":"18F-AlF-NOTA-FAPI-04 Superior to 18F-FDG PET\/CT in Detecting Primary Tumor and Metastatic Lymph Nodes in a Cervical Cancer Patient","author":"Wei","year":"2024","journal-title":"Clin. Nucl. Med."},{"issue":"7","key":"10.1016\/j.bcp.2025.117417_b0795","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2025.117417_b0800","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gene.2019.02.058","article-title":"A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis","volume":"699","author":"Zhang","year":"2019","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0805","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41368-023-00273-w","article-title":"A novel saliva-based miRNA profile to diagnose and predict oral cancer","volume":"16","author":"Balakittnen","year":"2024","journal-title":"Int. J. Oral Sci."},{"issue":"18","key":"10.1016\/j.bcp.2025.117417_b0810","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.3390\/ijms231810396","article-title":"A Study on the Prediction of Cancer using Whole-Genome Data and Deep Learning","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0815","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1038\/s41598-023-32332-x","article-title":"Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer","volume":"13","author":"Azari","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b0820","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5114\/wo.2014.47136","article-title":"Review the Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"1A","author":"Tomczak","year":"2015","journal-title":"Wsp\u00f3\u0142czesna Onkologia"},{"key":"10.1016\/j.bcp.2025.117417_b0825","doi-asserted-by":"crossref","unstructured":"S. Yerukala Sathipati, M.-J. Tsai, S. K. Shukla, and S.-Y. Ho, \u2018Artificial intelligence-driven pan-cancer analysis reveals miRNA signatures for cancer stage prediction\u2019, Human Genetics and Genomics Advances, vol. 4, no. 3, p. 100190, Jul. 2023, doi: 10.1016\/j.xhgg.2023.100190.","DOI":"10.1016\/j.xhgg.2023.100190"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0830","doi-asserted-by":"crossref","first-page":"30477","DOI":"10.1038\/s41598-025-99754-7","article-title":"Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis","volume":"15","author":"Singh","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b0835","doi-asserted-by":"crossref","unstructured":"Y. O. Nunez Lopez, B. Victoria, P. Golusinski, W. Golusinski, and M. M. Masternak, \u2018Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes\u2019, Reports of Practical Oncology & Radiotherapy, vol. 23, no. 1, pp. 6\u201320, Jan. 2018, doi: 10.1016\/j.rpor.2017.10.003.","DOI":"10.1016\/j.rpor.2017.10.003"},{"key":"10.1016\/j.bcp.2025.117417_b0840","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2019.01.006","article-title":"Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis","volume":"64","author":"Kumar","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2025.117417_b0845","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-024-01260-x","article-title":"Efficacy and Mechanism of Combining Radiotherapy and Immunotherapy in Stage IV Non-Small Cell Lung Cancer","author":"Wang","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117417_b0850","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41388-022-02209-w","article-title":"LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer","volume":"41","author":"Qiao","year":"2022","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0855","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00262-024-03754-x","article-title":"High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer","volume":"73","author":"Eric","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b0860","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00262-020-02520-z","article-title":"Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model","volume":"69","author":"Rodriguez-Barbosa","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bcp.2025.117417_b0865","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1344858","article-title":"MicroRNA-126 selected with broad-spectrum analysis of microRNAs \u2013 a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?","volume":"15","author":"Grenda","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0870","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s40263-025-01204-5","article-title":"Tofersen: a Review in Amyotrophic Lateral Sclerosis Associated with SOD1 Mutations","volume":"39","author":"McGuigan","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2025.117417_b0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.100862","article-title":"Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study","volume":"39","author":"G\u00fcnther","year":"2024","journal-title":"The Lancet Regional Health - Europe"},{"key":"10.1016\/j.bcp.2025.117417_b0880","doi-asserted-by":"crossref","DOI":"10.1177\/10600280251332500","article-title":"Onge, \u2018Olezarsen for the Treatment of Familial Chylomicronemia Syndrome\u2019","author":"Phillips","year":"2025","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0885","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40001-023-01627-0","article-title":"Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation","volume":"29","author":"Dhoundiyal","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b0890","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013Adjuvant or Adjuvant-only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b0895","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/onc.2015.96","article-title":"MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity","volume":"35","author":"Xue","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0900","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1038\/s41598-020-65680-z","article-title":"Differential miRNAs expression pattern of irradiated breast cancer cell lines is correlated with radiation sensitivity","volume":"10","author":"Masoudi-Khoram","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b0905","doi-asserted-by":"crossref","unstructured":"N. M. Hiers, T. Li, C. M. Traugot, and M. Xie, \u2018Target\u2010directed microRNAdegradation: Mechanisms, significance, and functional implications\u2019, WIREs RNA, vol. 15, no. 2, Mar. 2024, doi: 10.1002\/wrna.1832.","DOI":"10.1002\/wrna.1832"},{"issue":"13","key":"10.1016\/j.bcp.2025.117417_b0910","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or Tumor Suppressor? the Duplicity of MicroRNAs in Cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0915","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12672-025-02227-6","article-title":"A comprehensive review on targeted therapies for triple negative breast cancer: an evidence-based treatment guideline","volume":"16","author":"Emara","year":"2025","journal-title":"Discov. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0920","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117417_b0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100037","article-title":"Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: a comprehensive analysis","volume":"4","author":"Mehraj","year":"2022","journal-title":"Advances in Cancer Biology - Metastasis"},{"issue":"21","key":"10.1016\/j.bcp.2025.117417_b0930","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.3390\/cancers14215180","article-title":"The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-negative Breast Cancer","volume":"14","author":"Adinew","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117417_b0935","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41389-021-00309-y","article-title":"MYB oncoproteins: emerging players and potential therapeutic targets in human cancer","volume":"10","author":"Cicir\u00f2","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2025.117417_b0940","doi-asserted-by":"crossref","unstructured":"R. Bayley, C. Ward, and P. Garcia, \u2018MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential\u2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1874, no. 2, p. 188407, Dec. 2020, doi: 10.1016\/j.bbcan.2020.188407.","DOI":"10.1016\/j.bbcan.2020.188407"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0945","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41698-023-00461-1","article-title":"Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention","volume":"7","author":"Lee","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bcp.2025.117417_b0950","article-title":"CircUBAP2 Promotes MMP9-Mediated Oncogenic effect via Sponging miR-194-3p in Hepatocellular Carcinoma","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"23","key":"10.1016\/j.bcp.2025.117417_b0955","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/onc.2014.248","article-title":"CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress","volume":"34","author":"Sarmento","year":"2015","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0960","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.3390\/cimb44120398","article-title":"Checkpoint Kinase 1 (CHK1) Functions as both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal transition (EMT) in Triple-negative Breast Cancer","volume":"44","author":"Kim","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0965","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12935-021-02372-2","article-title":"FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma","volume":"22","author":"Wang","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b0970","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s12013-024-01388-5","article-title":"TYMS Knockdown Suppresses Cells Proliferation, Promotes Ferroptosis via Inhibits PI3K\/Akt\/mTOR Signaling Pathway Activation in Triple negative Breast Cancer","volume":"82","author":"Wang","year":"2024","journal-title":"Cell Biochem. Biophys."},{"issue":"18","key":"10.1016\/j.bcp.2025.117417_b0975","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.3390\/ijms231810823","article-title":"Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers","volume":"23","author":"Shen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b0980","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s10038-018-0510-3","article-title":"Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3","volume":"63","author":"Toda","year":"2018","journal-title":"J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.bcp.2025.117417_b0985","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/gcc.22982","article-title":"MicroRNA\u2010192\u20105p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19","volume":"60","author":"Vajen","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bcp.2025.117417_b0990","unstructured":"\u2018NIH-SEER-Cancer Stat Facts: Melanoma of the Skin\u2019. Accessed: May 14, 2025. [Online]. Available: https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b0995","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40364-023-00452-1","article-title":"The function and clinical implication of YTHDF1 in the human system development and cancer","volume":"11","author":"Ren","year":"2023","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b1000","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","article-title":"Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b1005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1535-7163.MCT-10-0799","article-title":"BRAFV600E: Implications for Carcinogenesis and Molecular Therapy","volume":"10","author":"Cantwell-Dorris","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b1010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","article-title":"Oncogenic Braf Induces Melanocyte Senescence and Melanoma in mice","volume":"15","author":"Dhomen","year":"2009","journal-title":"Cancer Cell"},{"issue":"54","key":"10.1016\/j.bcp.2025.117417_b1015","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1038\/sj.onc.1208152","article-title":"Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines","volume":"23","author":"Tanami","year":"2004","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b1020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/pcmr.12216","article-title":"Genomewide RNA i screen identifies protein kinase C \u03b2 and new members of mitogen\u2010activated protein kinase pathway as regulators of melanoma cell growth and metastasis","volume":"27","author":"Sch\u00f6nherr","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117417_b1025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21037\/atm-22-1163","article-title":"Identification of significant genes with a poor prognosis in skin cutaneous malignant melanoma based on a bioinformatics analysis","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b1030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.2353\/ajpath.2009.080543","article-title":"Gab2-Mediated Signaling Promotes Melanoma Metastasis","volume":"174","author":"Horst","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b1035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13148-020-00910-9","article-title":"Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis","volume":"12","author":"Azevedo","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"11","key":"10.1016\/j.bcp.2025.117417_b1040","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1093\/nar\/gkac494","article-title":"TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers","volume":"50","author":"McIntyre","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b1045","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-04-3045","article-title":"Tbx2 is Overexpressed and Plays an Important Role in Maintaining Proliferation and suppression of Senescence in Melanomas","volume":"65","author":"Vance","year":"2005","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117417_b1050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2014.03.011","article-title":"RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion","volume":"348","author":"Boregowda","year":"2014","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.bcp.2025.117417_b1055","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1158\/0008-5472.CAN-10-4410","article-title":"Splicing factor hnRNP A2\/B1 Regulates Tumor Suppressor Gene Splicing and is an Oncogenic driver in Glioblastoma","volume":"71","author":"Golan-Gerstl","year":"2011","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.bcp.2025.117417_b1060","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.1073\/pnas.96.17.9689","article-title":"Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma","volume":"96","author":"Ge","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"D1","key":"10.1016\/j.bcp.2025.117417_b1065","doi-asserted-by":"crossref","first-page":"D142","DOI":"10.1093\/nar\/gkz1022","article-title":"miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database","volume":"48","author":"Kehl","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117417_b1070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/OTT.S235862","article-title":"miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP","volume":"13","author":"Yang","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"10","key":"10.1016\/j.bcp.2025.117417_b1075","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/emboj.2011.102","article-title":"microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C","volume":"30","author":"Penna","year":"2011","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b1080","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1186\/s12885-021-09039-1","article-title":"IRF4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p\/C1QB axis","volume":"21","author":"Zheng","year":"2021","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b1085","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/genes12121931","article-title":"MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase reverse Transcriptase","volume":"12","author":"Taraz\u00f3n","year":"2021","journal-title":"Genes (Basel)"},{"issue":"12","key":"10.1016\/j.bcp.2025.117417_b1090","first-page":"1824","article-title":"\u2018Update of Incidence, Prevalence, Survival, and initial Treatment in patients with Non\u2013Small Cell Lung Cancer in the US\u2019, JAMA","volume":"7","author":"Ganti","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.bcp.2025.117417_b1095","unstructured":"\u2018NIH-SEER-Cancer Stat Facts: Lung and Bronchus Cancer\u2019. Accessed: May 20, 2025. [Online]. Available: https:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html."},{"issue":"8","key":"10.1016\/j.bcp.2025.117417_b1100","first-page":"8324","article-title":"\u2018CCNA2 facilitates epithelial-to-mesenchymal transition via the integrin \u03b1v\u03b23 signaling in NSCLC.\u2019, Int","volume":"10","author":"Ruan","year":"2017","journal-title":"J Clin Exp Pathol"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b1105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s42003-021-02003-6","article-title":"\u03b1v\u03b23 Integrin induces partial EMT independent of TGF-\u03b2 signaling","volume":"4","author":"Kariya","year":"2021","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117417_b1110","doi-asserted-by":"crossref","first-page":"Nov","DOI":"10.3892\/mmr.2021.12429","article-title":"Inhibin \u03b2A is an independent prognostic factor that promotes invasion via Hippo signaling in non\u2013small cell lung cancer","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2025.117417_b1115","article-title":"Knockdown of Inhibin Beta a Reversed the Epithelial Growth factor Receptor Tyrosine Kinase Inhibitor Resistance and Enhanced the Therapeutic effect of Radiotherapy in Non-Small Cell Lung Cancer","author":"Liu","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bcp.2025.117417_b1120","doi-asserted-by":"crossref","unstructured":"F. Zhan et al., \u2018CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.\u2019, Blood, vol. 109, no. 11, pp. 4995\u20135001, Jun. 2007, doi: 10.1182\/blood-2006-07-038703.","DOI":"10.1182\/blood-2006-07-038703"},{"key":"10.1016\/j.bcp.2025.117417_b1125","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1449466","article-title":"Exploring the oncogenic role and prognostic value of CKS1B in human lung adenocarcinoma and squamous cell carcinoma","volume":"16","author":"Hossain","year":"2025","journal-title":"Front. Genet."},{"key":"10.1016\/j.bcp.2025.117417_b1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111828","article-title":"CKS1B regulates the radiosensitivity of lung cancer via activating the PI3K\/AKT signaling pathway","volume":"132","author":"Lu","year":"2025","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b1135","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.7150\/thno.41120","article-title":"HIF-1\u0251-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt\/\u03b2-catenin and Notch signaling","volume":"10","author":"Jiang","year":"2020","journal-title":"Theranostics"},{"issue":"D1","key":"10.1016\/j.bcp.2025.117417_b1140","doi-asserted-by":"crossref","first-page":"D812","DOI":"10.1093\/nar\/gkw1079","article-title":"dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers","volume":"45","author":"Yang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"31","key":"10.1016\/j.bcp.2025.117417_b1145","doi-asserted-by":"crossref","first-page":"11578","DOI":"10.1021\/acs.analchem.3c02541","article-title":"Quantification of Multiplex miRNAs by Mass Spectrometry with Duplex-specific Nuclease-Mediated Amplification","volume":"95","author":"Qian","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bcp.2025.117417_b1150","doi-asserted-by":"crossref","unstructured":"P. Li et al., \u2018Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4.\u2019, J Biol Chem, vol. 285, no. 29, pp. 22713\u201322, Jul. 2010, doi: 10.1074\/jbc.M110.105692.","DOI":"10.1074\/jbc.M110.105692"},{"issue":"17\u201318","key":"10.1016\/j.bcp.2025.117417_b1155","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA Therapeutics: from Preclinical to Clinical Studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b1160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41419-023-06117-z","article-title":"Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma","volume":"14","author":"Bassot","year":"2023","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2025.117417_b1165","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/dmd.115.064493","article-title":"Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity","volume":"43","author":"Li","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b1170","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr3693","article-title":"MicroRNA-18a inhibits hypoxia-inducible factor 1\u03b1 activity and lung metastasis in basal breast cancers","volume":"16","author":"Krutilina","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117417_b1175","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/mc.22380","article-title":"MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras","volume":"55","author":"Fang","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2025.117417_b1180","doi-asserted-by":"crossref","unstructured":"A. B. Engin and A. Engin, \u2018Nanoparticle Mediated Epigenetic and Immunological Modulation\u2019, in Nanosafety, Cham: Springer Nature Switzerland, 2025, pp. 87\u2013114. doi: 10.1007\/978-3-031-93871-9_4.","DOI":"10.1007\/978-3-031-93871-9_4"},{"key":"10.1016\/j.bcp.2025.117417_b1185","doi-asserted-by":"crossref","unstructured":"J. Miniarikova et al., \u2018Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington\u2019s Disease.\u2019, Mol Ther Nucleic Acids, vol. 5, no. 3, p. e297, Mar. 2016, doi: 10.1038\/mtna.2016.7.","DOI":"10.1038\/mtna.2016.7"},{"key":"10.1016\/j.bcp.2025.117417_b1190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtm.2019.09.010","article-title":"AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes","volume":"15","author":"Keskin","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"7","key":"10.1016\/j.bcp.2025.117417_b1195","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/1947601911425832","article-title":"Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity","volume":"2","author":"Ru","year":"2011","journal-title":"Genes Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2025.117417_b1200","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs Regulate CYP3A4 Expression via Direct and indirect Targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.bcp.2025.117417_b1205","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3390\/cancers12102810","article-title":"Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma","volume":"12","author":"Pratama","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"46","key":"10.1016\/j.bcp.2025.117417_b1210","doi-asserted-by":"crossref","first-page":"27920","DOI":"10.18632\/oncotarget.24723","article-title":"MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab","volume":"9","author":"Cataldo","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bcp.2025.117417_b1215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118745","article-title":"A Novel MiRNA-Based Predictive Model for Biochemical failure following Post-Prostatectomy Salvage Radiation Therapy","volume":"10","author":"Bell","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117417_b1220","article-title":"Overview of MicroRNA Expression in predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer \u2013 a Systematic Review","volume":"16","author":"Davey","year":"2022","journal-title":"Breast Cancer (Auckl.)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b1225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41408-024-01193-6","article-title":"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao","year":"2024","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.bcp.2025.117417_b1230","article-title":"Challenges and opportunities in microRNA-based cancer therapeutics","volume":"6","author":"Ju","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117417_b1235","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41419-019-1671-5","article-title":"Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2\/AKT\/\u03b2-catenin pathway in glioma","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117417_b1240","doi-asserted-by":"crossref","unstructured":"S. R. Martens-de Kemp et al., \u2018Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature\u2019, Neoplasia, vol. 32, p. 100820, Oct. 2022, doi: 10.1016\/j.neo.2022.100820.","DOI":"10.1016\/j.neo.2022.100820"},{"issue":"15","key":"10.1016\/j.bcp.2025.117417_b1245","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/0008-5472.CAN-14-0404","article-title":"miRNA-128 Suppresses Prostate Cancer by Inhibiting BMI-1 to Inhibit Tumor-Initiating Cells","volume":"74","author":"Jin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117417_b1250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2018.10.038","article-title":"Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models","volume":"442","author":"Tu","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117417_b1255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01695-6","article-title":"MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis","volume":"22","author":"Khan","year":"2023","journal-title":"Mol. Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:27:16Z","timestamp":1769477236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":251,"alternative-id":["S0006295225006823"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117417","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-oncogene targeting in cancer therapy: A miRNA-driven pharmacological approach","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117417"}}